Estrogen Modulates NFκB Signaling by Enhancing IκBα Levels and Blocking p65 Binding at the Promoters of Inflammatory Genes via Estrogen Receptor-β
Dongqi Xing(University of Alabama at Birmingham), Susan E. Nozell(Baze University), Kaizheng Gong(Northern Jiangsu People's Hospital), Hao Yu(Wenzhou Medical University), Jonathan Black(University of Alabama at Birmingham), Suzanne Oparil(University of Alabama at Birmingham), Wenguang Feng(Inner Mongolia Medical University), Yiu-Fai Chen(University of Alabama at Birmingham)
Cited by 145
Related Papers
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|5.4k
A Controlled Trial of Renal Denervation for Resistant Hypertension
|New England Journal of Medicine|2014|2.2k